Piña, Pamela
Lorenzatti, Daniel
Filtz, Annalisa
Scotti, Andrea
Gil, Elena Virosta
Torres, Juan Duarte
Perea, Cristina Morante
Shaw, Leslee J.
Lavie, Carl J.
Berman, Daniel S.
Iacobellis, Gianluca
Slomka, Piotr J.
Pibarot, Philippe
Dweck, Marc R.
Dey, Damini
Garcia, Mario J.
Latib, Azeem
Slipczuk, Leandro
Article History
Received: 16 September 2024
Accepted: 12 December 2024
First Online: 18 January 2025
Declarations
:
: This is an observational study. The study protocol followed the ethical guidelines of the 1975 Declaration of Helsinki as reflected in the a priori approval by the Institution’s Human Research Committee. The study was approved by our Office of Human Research Affairs at Albert Einstein College of Medicine and consent was waived due to study design.
: Annalisa Filtz, Daniel Lorenzatti, and Leandro Slipczuk are supported by institutional grants from Amgen and Philips. Damini Dey received grant support from the National Heart, Lung, and Blood Institute, software royalties from Cedars-Sinai Medical Center, and holds a patent (US8885905B2 in USA and WO patent WO2011069120A1, Method and System for Plaque Characterization). Others have nothing to declare.
: Damini Dey received grant support from the National Heart, Lung, and Blood Institute, software royalties from Cedars-Sinai Medical Center, and holds a patent (US8885905B2 in USA and WO patent WO2011069120A1, Method and System for Plaque Characterization). Others have nothing to declare.